Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia-Reference-Cited by-同舟云学术

Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia

Published:2022-01 Issue: Volume:97 Page:105192
ISSN:1567-1348
Container-title:Infection, Genetics and Evolution
language:en
Short-container-title:Infection, Genetics and Evolution

Author:

Gálvez Jubby Marcela,Chaparro-Solano Henry Mauricio,Pinzón-Rondón Ángela María,Albornoz Ludwig L.,Pardo-Oviedo Juan Mauricio,Zapata-Gómez Fabio Andrés,Patiño-Aldana Andrés Felipe,Hernández-Rodríguez Andrea del Pila,Díaz-Quiroz Mateo,Ruiz-Sternberg Ángela María

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics,Microbiology

Reference44 articles.

1. Mutational analysis of SARS-CoV-2 ORF8 during six months of COVID-19 pandemic;Alkhansa;Gene Rep.,2021

2. SARS-CoV-2 sequencing: the technological initiative to strengthen early warning systems for public health emergencies in Latin America and the Caribbean;Álvarez-Díaz;Biomed.: Revista Inst. Nacional Salud,2020

3. Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma;Cele;MedRxiv,2021

4. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan;Chan;Emerg. Microb. Infect.,2020

5. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;Chan;Lancet (London, England),2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neglected SARS-CoV-2 variants and potential concerns for molecular diagnostics: a framework for nucleic acid amplification test target site quality assurance;Microbiology Spectrum;2023-12-12

2. Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing;Scientific Reports;2023-11-22

3. Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8+ T cells;Frontiers in Immunology;2023-11-03

4. Inhibitors of SARS-CoV-2 main protease: Biological efficacy and toxicity aspects;Toxicology in Vitro;2023-10

5. Different Variants of SARS-CoV-2: A Comprehensive Review on Mutation Patterns and Pathogenicity;Coronaviruses;2023-02